Cargando…
COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis
The post-coronavirus disease (COVID-19) mucormycosis is a deadly addition to the pandemic spectrum. Although it’s a rare, aggressive, and opportunistic disease, the associated morbidity and mortality are significant. The complex interplay of factors aggravating CAM is uncontrolled diabetes, irration...
Autores principales: | Samson, Rachel, Dharne, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647065/ https://www.ncbi.nlm.nih.gov/pubmed/34900512 http://dx.doi.org/10.1007/s13205-021-03080-4 |
Ejemplares similares
-
Biosensors: frontiers in rapid detection of COVID-19
por: Samson, Rachel, et al.
Publicado: (2020) -
Probiotics in the prophylaxis of COVID-19: something is better than nothing
por: Gohil, Kushal, et al.
Publicado: (2020) -
The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review
por: Sarfraz, Zouina, et al.
Publicado: (2022) -
COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022) -
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
por: García-Carnero, Laura C., et al.
Publicado: (2022)